"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
15,"no","yes","Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome",2018,"Human Reproduction","10.1093/humrep/dey343","Brower","Mark Goodarzi","mark.goodarzi@cshs.org","Division of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Room B-131, Los Angeles, CA 90048, USA","Effect of body mass index on PCOS","Women with PCOS have a high prevalence (50–70%) of overweight and obesity, with obesity exacerbating the PCOS phenotype","Two-sample summary-level","PCOS","polycystic ovary syndrome","reproductive","polycystic ovary syndrome","Current study","Not discussed","both","750","1567",NA,NA,NA,"case/control","European ancestry","BMI","BMI","Locke 2015 BMI All ancestries both","not discussed","both","not discussed","339224",NA,"Healthy","European ancestry",NA,NA,NA,NA,"5x10-8",NA,"LD R2 > 0.8","Not discussed",NA,NA,"92","97","4 SNPs not available in outcome and 1 SNP did not meet MR inclusion criteria","no",NA,"Inverse variance weighted (fixed effects)","Maximum likelihood","MR Egger",NA,NA,NA,"Consistent with IVW","F statistic > 10","R","TwoSampleMR","Not discussed","Not discussed","Not discussed","SD inverse rank normal transform","case/control","OR","4.8899999999999997",NA,"95","1.46","16.32","Not given",NA,NA,"Not discussed","Not discussed","Not discussed","Not discussed",NA,96
37,"no","yes","Causal mechanisms and balancing selection inferred from genetic associations with polycysticovary syndrome",2015,"Nature Communications","10.1038/ncomms9464","Day","John R.B. Perry","john.perry@mrc-epid.cam.ac.uk","MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, CB2 0QQ","Effect of body mass index on polycystic ovary syndrome","Phenotypic heterogeneity between cases has limited the ability to make definitive conclusions regarding its aetiology and pathophysiology. Obesity is associated with PCOS, but its causal role has yet to be determined3; alternative explanations include reverse causality (that is, PCOS increases susceptibility to weight gain) and synergistic but independent roles for obesity and PCOS in infertility","One-sample","PCOS","polycystic ovary syndrome","reproductive","Self-reported polycystic ovary syndrome","Current study","18+","women","6368","88558","7229","181645","Seems like the MR analysis was limited to two of the cohorts, while the original GWAS in the papers used all cohorts - which would explain the discrepancy. I got the N for the study by adding the 23 and me numbers to the Rotterdam numbers (both in Supp Table 1)","Healthy","White European","BMI","BMI","Speliotes 2010 BMI Europeans both","18+","Not discussed","Not discussed","249796","Not discussed","Healthy","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,"32","32",NA,"Not discussed",NA,"Not discussed","Funnel plot","Not discussed",NA,NA,NA,"Said they did sensitivity analysis but only discuss a funnel plot","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Correction for 15 exposures P < 0.0033","SD","Case/control","OR","1.9",NA,"95","1.55","2.34","2.5x10-9","None",NA,"The limitations of Mendelian randomization analyses are well-recognized; its major assumptions regarding lack of heterogeneity and pleiotropy are supported by the consistency of our findings across individual SNPs. Furthermore, the reported inverse association between the insulin resistance genetic score and BMI25 might attenuate our observed positive univariate effects of these traits on PCOS risk. Other uncertainties remain, such as possible canalization and age-specific effects","Sensitivity analyses performed, but not discussed.","Not discussed","Not discussed","The case numbers don’t add up, possible that they used >1 criteria per person",644
38,"no","yes","Large-scalegenome-widemeta-analysisofpolycysticovarysyndromesuggestssharedgeneticarchitecturefordifferentdiagnosiscriteria",2018,"PLOS Genetics","10.1371/journal.pgen.1007813","Day","Corrine K. Welt","cwelt@genetics.utah.edu","Division of Endocrinology, Metabolism and Diabetes, University of Utah, Salt Lake City, Utah, United States of America, Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America","Effect of body mass index on polycystic ovary syndrome","PCOS is commonly associated with insulin resistance, pancreatic beta cell dysfunction, obesity and type 2 diabetes (T2D). These metabolic abnormalities are most pronounced in women with the NIH phenotype [12]. In addition, the odds for moderate or severe depression and anxiety disorders are higher in women with PCOS [13]. However, the mechanisms behind the association between the reproductive, metabolic and psychiatric features of the syndrome remain largely unknown.","One-sample","PCOS","polycystic ovary syndrome","reproductive","PCOS according to the NIH (2,540 cases and 15,020 controls) or Rotterdam criteria (2,669 cases and 17,035 controls), or by self reported diagnosis (5,184 cases and 82,759 controls)","Current study","18+","both","10074","103164",NA,NA,NA,"Healthy","European","BMI","BMI","Not discussed","18+","both","Not discussed",NA,"Not discussed","Healthy","European","Not discussed","Not discussed","To assess the level of shared etiology between PCOS and related traits, we performed genetic correlation analysis using LD-score regression.","Not discussed","5×10−8","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed",NA,"Not discussed","Not discussed",NA,"Inverse variance weighted","MR Egger",NA,NA,NA,NA,"Removed BMI associated variants as sensitivity, which attenuated effect ""The importance of BMI pathways on reproductive phenotypes was further demonstrated by the attenuation of significance of Mendelian randomization analysis for age-at-menarche when BMI-associated variants were excluded from the analysis.""","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","kg/m2","Case/control","beta","0.72","7.1999999999999995E-2",NA,NA,NA,"1.56x10-23","None",NA,"No discussion of where BMI instruments are from or how many. The links between PCOS and depression might be complicated by pathways that are also related to BMI, as BMI pathways are causal in both PCOS and depression","Not discussed","Not discussed","Not discussed",NA,645
